EnWave inks powderREV machine supply agreement for enzyme production in Canada
date:Apr 18, 2013
he process with a targeted annual return of between 30% and 50% on capital invested, subject to overall capacity utilization.

Before the large scale commercial production by the machinery begins, a start-up approval process will be conducted after the initial installation in order to confirm acceptance by the Licensee's end customers.

EnWave chairman and co-ceo Tim Durance said that the commercial license offers a new high vale market for the company.

We continue to gain commercial traction f
3/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/09 07:09